An extraordinarily sensitive new blood test has been developed that promises to be able to effectively track the progression of breast cancer at its earliest stages. It is suggested the blood test could track the efficacy of drug therapies better than current imaging techniques and prevent unnecessary surgical procedures or needless extra doses of chemotherapy.
Alkahest, a California-based biotech start-up, has just revealed some compelling early results from an ongoing Phase 2 trial into the efficacy of its novel formulation of plasma proteins derived from young blood, developed to slow, or even stop, the cognitive decline associated with Alzheimer’s disease.
from Brent Smith for World Net Daily:
According to leading polls of Democratic primary voters, health care is still one the top issues. And it took center stage, as a new human right, by means of the new progressive socialist tag-team, Bernie Sanders and Elizabeth Warren, during Tuesday’s Democratic debate.
On night 2, there was not the unbridled enthusiasm for the Sanders-Warren Medicare for All scheme, as Joe Biden threw cold water on it and defended Obamacare. But he appears to be one of only a few. To many of the rest, it’s like Obamacare never existed – like it had no positive effect on “health care” at all.
It didn’t, by the way.
The over-abundance or lack of certain types of gut bacteria has been linked to everything from depression to heart disease to childhood asthma. Non-invasively determining which microbes make up a person’s “gut microbiome,” however, can be difficult – which is why a new 3D-printed capsule was developed.
Bone marrow transplants are a common treatment for certain conditions related to the blood, but the patient’s immune system can often react badly to the foreign cells and attack them. Mesenchymal stromal cells (MSCs) may help, but they too can be cleared out by immune cells. Now, a Harvard team has shown that coating MSCs in a thin hydrogel can protect them, making bone marrow transplants more successful.
Too often the surgical removal of cancer or its elimination through chemo or radiotherapy isn’t the end of the story, but where do the relapses come from? Part of the explanation may lay in what are known as cancer stem cells, which could be thought of as little seedlings that hide away in the body’s tissues until they feel the time is right to return to action. A newly discovered molecule has raised hopes of cutting these crafty critters off at the source, with early experiments demonstrating how it can latch onto cancer stem cells and starve them of what they need to survive.
Cancer can be a tricky foe, so the best way to fight it might not be with a direct attack, but to cut off its supply lines. One such method, known as gas embolotherapy, involves creating tiny bubbles in the tumor blood vessels, which block the blood supply and starve the cancer out. Now, researchers from China and France have found that the technique could also deal a second blow as a drug delivery system.